Tag Archives: Spending

340B found to have minimal effect on pricing, countering notion that it’s a driver of healthcare spending

The 340B drug discount program has been a source of controversy, with the pharmaceutical industry claiming that it’s one of the main drivers of rising healthcare spending. But a study from the Medicare Payment Advisory Commission challenges that assertion, finding that its effect on cost sharing for patients is minimal. For hospitals participating in 340B,… Read More »